Aims
This study investigated the safety and efficacy of remote ischemic conditioning (RIC) on ameliorating the sequelae of ischemic moyamoya disease (iMMD).
Methods
A total of 30 iMMD patients underwent longâterm RIC and were followed up at 0.5, 1, and 2Â years for clinical outcomes, including frequency of stroke recurrence, Patient Global Impression of Change (PGIC) scale, peak systolic velocities (PSV), and cerebral perfusion.
Results
During the whole RIC treatment process, no RICârelated adverse event occurred. Only one of 30 patients suffered a onetime infarction (3.3%), and the ratios of acceptable PGIC were 88.2%, 64.3%, and 92.3% at 0.5, 1, and 2Â years followâup. KaplanâMeier analysis showed the frequency of stroke recurrence was significantly reduced after RIC (PÂ =Â .013). The frequency of TIA per week was 1.1 (0.6, 2.8) prior to RIC and 0.1 (0.0, 0.5) postâRIC (PÂ <Â .01). Compared to baseline, PSV values were significantly reduced after RIC treatment (PÂ =Â .002 at 0.5, PÂ =Â .331 at 1, and PÂ =Â .006 at 2Â years). In patients undergoing perfusion studies, 75% obtained improvement on followedâup SPECT and 95% on followedâup PET maps.
Conclusions
Remote ischemic conditioning may be beneficial on controlling iMMDâinduced ischemic events, relieving symptoms, and improving cerebral perfusion, without incidence of complications in this case series.